| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 8888888 |
Internal/system code - not a standard HCPCS code |
35,205 |
15,514 |
$14.59M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,060 |
15,346 |
$778K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
8,263 |
7,042 |
$347K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,246 |
1,741 |
$328K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
8,088 |
7,102 |
$327K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,407 |
2,245 |
$292K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,235 |
955 |
$279K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
12,037 |
10,377 |
$269K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,337 |
2,138 |
$241K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
8,625 |
7,349 |
$225K |
| 80050 |
General health panel |
2,767 |
2,494 |
$175K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
6,923 |
5,488 |
$150K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
2,469 |
2,209 |
$115K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
5,936 |
4,546 |
$114K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,217 |
2,021 |
$112K |
| J2704 |
Injection, propofol, 10 mg |
6,716 |
4,985 |
$98K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
2,581 |
2,082 |
$67K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
6,851 |
5,296 |
$63K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
1,065 |
776 |
$62K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
2,742 |
2,390 |
$61K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,008 |
4,910 |
$60K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
762 |
630 |
$57K |
| 70450 |
Computed tomography, head or brain; without contrast material |
2,253 |
2,007 |
$51K |
| 71046 |
Radiologic examination, chest; 2 views |
2,329 |
2,047 |
$48K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
5,193 |
3,861 |
$47K |
| 85027 |
|
1,553 |
1,306 |
$41K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
5,460 |
4,770 |
$41K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
8,801 |
6,391 |
$39K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
3,299 |
2,256 |
$37K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,994 |
6,815 |
$34K |
| 87186 |
|
1,440 |
1,248 |
$32K |
| 82330 |
|
2,063 |
1,801 |
$30K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,180 |
1,022 |
$27K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
140 |
130 |
$27K |
| 87070 |
|
709 |
605 |
$27K |
| 81001 |
|
8,003 |
6,974 |
$27K |
| 71045 |
Radiologic examination, chest; single view |
3,756 |
3,303 |
$26K |
| 86901 |
|
1,385 |
1,121 |
$25K |
| 80053 |
Comprehensive metabolic panel |
16,841 |
13,308 |
$23K |
| J2060 |
Injection, lorazepam, 2 mg |
1,892 |
1,538 |
$23K |
| J1630 |
Injection, haloperidol, up to 5 mg |
1,220 |
1,039 |
$23K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
3,340 |
2,741 |
$22K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,965 |
1,750 |
$22K |
| 85610 |
|
2,227 |
1,800 |
$21K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
282 |
180 |
$20K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
1,926 |
1,567 |
$18K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
2,756 |
2,450 |
$16K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,915 |
2,437 |
$15K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
121 |
97 |
$15K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,143 |
1,773 |
$14K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
2,564 |
2,304 |
$14K |
| 84702 |
|
4,326 |
3,838 |
$14K |
| 94729 |
|
186 |
174 |
$13K |
| 83690 |
|
5,440 |
4,676 |
$12K |
| 81025 |
|
979 |
872 |
$12K |
| G0382 |
Level 3 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) |
92 |
90 |
$12K |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
16 |
16 |
$11K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,124 |
951 |
$11K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,610 |
2,352 |
$11K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
598 |
558 |
$11K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
59 |
52 |
$9K |
| J1644 |
Injection, heparin sodium, per 1000 units |
740 |
464 |
$9K |
| 86850 |
|
765 |
578 |
$8K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
204 |
188 |
$8K |
| 96376 |
|
1,295 |
1,117 |
$7K |
| A9585 |
Injection, gadobutrol, 0.1 ml |
808 |
722 |
$7K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
326 |
293 |
$7K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,669 |
1,307 |
$7K |
| 73630 |
|
201 |
188 |
$7K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
3,355 |
2,924 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
805 |
747 |
$6K |
| 84484 |
|
4,156 |
3,456 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
805 |
747 |
$6K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
84 |
78 |
$6K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
312 |
275 |
$5K |
| 84100 |
|
1,304 |
776 |
$5K |
| 73562 |
|
116 |
110 |
$5K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
912 |
702 |
$5K |
| 85379 |
|
1,412 |
1,284 |
$4K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
28 |
27 |
$4K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,511 |
1,189 |
$4K |
| J1815 |
Injection, insulin, per 5 units |
171 |
103 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
899 |
814 |
$3K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
876 |
772 |
$3K |
| 87077 |
|
405 |
320 |
$3K |
| 83605 |
|
4,561 |
3,840 |
$3K |
| 59025 |
Fetal non-stress test |
156 |
62 |
$3K |
| 83735 |
|
3,277 |
2,077 |
$3K |
| 76801 |
|
142 |
124 |
$3K |
| 82565 |
|
87 |
80 |
$2K |
| J3490 |
Unclassified drugs |
159 |
146 |
$2K |
| 73130 |
|
58 |
54 |
$2K |
| 87210 |
|
235 |
221 |
$2K |
| 93971 |
|
127 |
117 |
$2K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
13 |
12 |
$2K |
| 84703 |
|
1,153 |
1,019 |
$2K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
878 |
716 |
$2K |
| 87040 |
|
724 |
530 |
$1K |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
30 |
26 |
$1K |
| 73030 |
|
49 |
45 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
66 |
60 |
$1K |
| 94010 |
|
144 |
135 |
$1K |
| 84439 |
|
437 |
374 |
$1K |
| 86140 |
|
1,075 |
924 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
54 |
53 |
$1K |
| 88307 |
|
43 |
43 |
$990.45 |
| 86900 |
|
852 |
632 |
$975.46 |
| 82803 |
|
890 |
809 |
$973.40 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
630 |
584 |
$924.62 |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
579 |
532 |
$889.89 |
| 90686 |
|
124 |
114 |
$888.71 |
| 83880 |
|
577 |
510 |
$848.58 |
| 87088 |
|
921 |
827 |
$847.45 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
205 |
185 |
$810.50 |
| 73610 |
|
45 |
40 |
$789.32 |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
13 |
12 |
$761.24 |
| 76882 |
|
16 |
12 |
$682.88 |
| 85651 |
|
755 |
631 |
$515.12 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
773 |
497 |
$482.74 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
24 |
21 |
$453.53 |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
213 |
182 |
$384.63 |
| 10060 |
|
15 |
14 |
$384.08 |
| 90694 |
|
16 |
15 |
$322.14 |
| 87081 |
|
28 |
24 |
$280.16 |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
13 |
12 |
$267.58 |
| 90662 |
|
17 |
16 |
$234.55 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
13 |
12 |
$214.76 |
| 80076 |
|
76 |
69 |
$184.40 |
| 80061 |
Lipid panel |
103 |
93 |
$167.05 |
| 82947 |
|
446 |
353 |
$148.60 |
| 82550 |
|
82 |
71 |
$120.89 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
367 |
341 |
$110.21 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
15 |
13 |
$102.81 |
| 82784 |
|
135 |
83 |
$102.72 |
| 76830 |
Ultrasound, transvaginal |
37 |
34 |
$70.83 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
175 |
159 |
$66.39 |
| 82607 |
|
29 |
28 |
$40.68 |
| 88342 |
|
125 |
117 |
$10.43 |
| 82248 |
|
135 |
75 |
$9.56 |
| 84132 |
|
445 |
384 |
$6.96 |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
85 |
72 |
$0.00 |
| 85730 |
|
134 |
116 |
$0.00 |
| G0378 |
Hospital observation service, per hour |
240 |
223 |
$0.00 |
| J1790 |
Injection, droperidol, up to 5 mg |
165 |
147 |
$0.00 |
| 83615 |
|
88 |
80 |
$0.00 |
| 86803 |
|
13 |
13 |
$0.00 |
| 70498 |
|
12 |
12 |
$0.00 |
| 82728 |
|
45 |
43 |
$0.00 |
| 88184 |
|
16 |
12 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
43 |
41 |
$0.00 |
| 88304 |
|
38 |
33 |
$0.00 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
32 |
29 |
$0.00 |
| 90870 |
|
43 |
12 |
$0.00 |
| 87147 |
|
13 |
12 |
$0.00 |
| 70496 |
|
13 |
13 |
$0.00 |
| 84478 |
|
14 |
14 |
$0.00 |
| 88185 |
|
16 |
12 |
$0.00 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
12 |
12 |
$0.00 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
27 |
24 |
$0.00 |
| 88302 |
|
25 |
24 |
$0.00 |
| 10061 |
|
18 |
15 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
15 |
12 |
$0.00 |
| M0220 |
Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), includes injection and post administration monitoring |
30 |
27 |
$0.00 |
| 87075 |
|
18 |
15 |
$0.00 |